AP
Apogee Therapeutics Inc. (APGE)
NASDAQ
135.07
0.00 (0.00%)
Closed
Sep 3, 2026
Day's Range
135.07135.07
52 wk Range
35.39135.09
Financial Statements - APGE - Apogee Therapeutics Inc.
Revenue
0
Net Income
-255.84M▼ 40.5%
EBITDA
-284.17M▼ 31.1%
Free Cash Flow
-232.59M▼ 35.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - |
| Gross Profit | - | - | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | -285.59M | -216.87M | -93M | -30.72M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | -255.56M | -182.12M | -83.98M | -39.78M |
| Income Tax | 278K | 18K | - | - |
| Net Income | -255.84M | -182.14M | -83.98M | -39.78M |
| EPS Basic | -3.740321 | -3.3 | -3.36 | -1.46017 |
| EPS Diluted | -3.740321 | -3.3 | -3.36 | -1.46017 |
| Basic Shares Outstanding | 68.40M | 55.19M | 25M | 27.24M |
| Diluted Shares Outstanding | 68.40M | 55.19M | 25M | 27.24M |
| Ebit | -285.59M | -216.87M | -83.98M | -30.63M |
| Ebitda | -284.17M | -216.68M | -83.98M | -30.63M |
| Net Income Continuous Operations | -255.84M | -182.14M | -83.98M | -39.78M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
